Fluroquinolones Flashcards
General features
- antimicrobial
- double ring of quinoline
- uncommon SE in TD
- competitive inhibition of CYP3A and CYP1A
- rapidly inhibit DNA synthesis by promoting cleavage of bacterial DNA -> rapid bacterial death
- Bacteriocidal , CONCENTRATION dependant.
- PAE: 2-5h
Spectrum
1st gen: not used anymore except for research. Nalidixic acid, oxalinic acid, cinoxacin
* Effective against Gram-ve. Enteric bacteria
2nd gen: 1-fluro: Flumequine(used in livestock) , Norfloxacin (topically) , mostly G- enteric bacteria. 2-fluro: Danofloxacin, Difloxacin, Enrofloxacin, Ibafloxacin, Marbofloxacin, Orbitfloxacin, Sarafloxacin
G-, modernately G+ (staph,strep,myco are resistant!) active against pseudomonas! (ciprofloxacin) , IC pathogens!
3rd gen (mainly hu):Balofloxacin, levofloxacin, sparfloxacin, temafloxacin : G+(+staph and strep). G- ,pseudomonas and IC pathogens
4th gen: (mainly hu): Pradofloxacin (used in vet) Gram+ve, Gram-ve, Pseudomonas, anaerobes, intracellular pathogens.
* effective against MRSA, streptococci, anaerobes( prevotella spp)
•
Resistance
- Chromosomal mutation
- gyrase A gene mutation- 1st gene resistance
- gytase A+B mutartion - full resistance
* freq in zoonotic E.coli, salmonela and campy
* membrane proteins
* inc. bacterial efflux
* Cross resistance is complete within the generations
* Plasmid mediated resistance
Pharmacokinetics
- except the 1st gen.
- absorption: excellent
- Distribution: Excellent, good good special barriers penetration (CSF, ocular)
- concentrated within phagocytic cells (reduction of survival of intracellular pathogens).
Metabolism
except 1st gen
- Partially metabolized , based on CYP450A
- metabolites may be active (Enrofloxacin to ciprofloxacin)
- Eliminiation: Kidneys as an active drug (UTI) , bile, enetrohepatic recirculation can prolong its action.
Indication
- used when thiere is no other antibiotic that can be used (to decrease ressistance)
- UTI, GI -best
- respiraroty,mycoplasmosis,soft tissue,pyoderma,osteomyelitis,prostitis,eye infection, gingivitis, meningitis
Side Effects
- inhibition of load bearing cartilage development
- retinopathy (fe)- blindness
- CNS sign (epilepsy)
- Dysbacteriosis (NOT in eq) , vertigo, dizziness,headache
- GI: vomitting,diarrhoea , abdominal pain
- photosensitivity , pruritis
- cardiac toxicity, hepatotoxicity
combination
- Synergic with: Betalactams, aminoglycosides, vancomycin
- staphiloccocus aureus: ciprofloxacin+azlocillin // levofloxacin + oxacillin
- pseudomonas aeruginosa (ciprofloxacin+imipenem/azlocillin/amikacin
- antagonistic interaction: chloramphenicol , rifampin